Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
10.67
+0.32 (3.09%)
Oct 16, 2025, 1:41 PM EDT - Market open

Nurix Therapeutics Stock Forecast

Stock Price Forecast

The 14 analysts that cover Nurix Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $28.14, which forecasts a 163.73% increase in the stock price over the next year. The lowest target is $15 and the highest is $35.

Price Target: $28.14 (+163.73%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$15$28.14$30$35
Change+40.58%+163.73%+181.16%+228.02%

Analyst Ratings

The average analyst rating for Nurix Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMay '25Jun '25Jul '25Aug '25Sep '25Oct '25
Strong Buy777775
Buy887777
Hold222222
Sell000000
Strong Sell000000
Total171716161614

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Morgan Stanley
Morgan Stanley
Hold
Maintains
$16$15
HoldMaintains$16$15+40.58%Oct 14, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$34$33
Strong BuyMaintains$34$33+209.28%Oct 14, 2025
Piper Sandler
Piper Sandler
Buy
Maintains
$35$32
BuyMaintains$35$32+199.91%Oct 10, 2025
Oppenheimer
Oppenheimer
Buy
Maintains
$30$28
BuyMaintains$30$28+162.42%Oct 10, 2025
Oppenheimer
Oppenheimer
Buy
Reiterates
$32$30
BuyReiterates$32$30+181.16%Jul 31, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
97.21M
from 54.55M
Increased by 78.20%
Revenue Next Year
62.72M
from 97.21M
Decreased by -35.48%
EPS This Year
-3.04
from -2.88
EPS Next Year
-3.70
from -3.04
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingNov 30, 2020Nov 30, 2021Nov 30, 2022Nov 30, 2023Nov 30, 2024Nov 30, 2025Nov 30, 2026
Revenue
17.82M29.75M38.63M76.99M54.55M97.21M62.72M
Revenue Growth
-42.73%66.95%29.84%99.31%-29.15%78.20%-35.48%
EPS
-2.76-2.73-3.71-2.65-2.88-3.04-3.70
EPS Growth
-------
Forward PE
-------
No. Analysts
-----2020
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High118.6M99.8M
Avg97.2M62.7M
Low74.5Mn/a

Revenue Growth

Revenue Growth20252026202720282029
High
117.4%
2.6%
Avg
78.2%
-35.5%
Low
36.5%
-

EPS Forecast

EPS20252026202720282029
High-2.86-2.07
Avg-3.04-3.70
Low-3.35-4.42

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.